Cargando…

Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease

Alzheimer's disease (AD) affects more than 18 million people worldwide and is characterized by progressive memory deficits, cognitive impairment and personality changes. The main cause of AD is generally attributed to the increased production and accumulation of amyloid-β (Aβ), in association w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farfara, D, Lifshitz, V, Frenkel, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401126/ https://www.ncbi.nlm.nih.gov/pubmed/18363841 http://dx.doi.org/10.1111/j.1582-4934.2008.00314.x

Ejemplares similares

Neuroprotective and Neurotoxic Effects of Glial-Derived Exosomes
por: Oyarce, Karina, et al.
Publicado: (2022)

Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide
por: Balez, Rachelle, et al.
Publicado: (2016)

Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application
por: Trudler, Dorit, et al.
Publicado: (2010)

Critical Involvement of Glial Cells in Manganese Neurotoxicity
por: Soto-Verdugo, Jazmín, et al.
Publicado: (2021)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
por: Ferreira, Carla, et al.
Publicado: (2020)

Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
por: Morigaki, Ryoma, et al.
Publicado: (2017)

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
por: Al-Ghraiybah, Nour F., et al.
Publicado: (2022)

Salsolinol—neurotoxic or Neuroprotective?
por: Kurnik-Łucka, Magdalena, et al.
Publicado: (2019)

Ketamine: Neuroprotective or Neurotoxic?
por: Choudhury, Divya, et al.
Publicado: (2021)

Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection
por: Lee, Kyung Hee, et al.
Publicado: (2021)

Are volatile anesthetics neuroprotective or neurotoxic?
por: Zuo, Zhiyi
Publicado: (2012)

Neuroprotective Herbs for the Management of Alzheimer’s Disease
por: Gregory, Julie, et al.
Publicado: (2021)

Commonalities between Copper Neurotoxicity and Alzheimer’s Disease
por: Patel, Roshni, et al.
Publicado: (2021)

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer’s disease
por: Heras-Sandoval, David, et al.
Publicado: (2016)

Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
por: Tolar, Martin, et al.
Publicado: (2021)

Ethanol and Cognition: Indirect Effects, Neurotoxicity and Neuroprotection: A Review
por: Brust, John C.M.
Publicado: (2010)

Intracellular Neuroprotective Mechanisms in Neuron-Glial Networks Mediated by Glial Cell Line-Derived Neurotrophic Factor
por: Mitroshina, Еlena V., et al.
Publicado: (2019)

Glial scars are permeable to the neurotoxic environment of chronic stroke infarcts
por: Zbesko, Jacob C., et al.
Publicado: (2018)

The Evolving Landscape of Neurotoxicity by Unconjugated Bilirubin: Role of Glial Cells and Inflammation
por: Brites, Dora
Publicado: (2012)

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
por: Iseki, Tatou, et al.
Publicado: (2023)

“Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies”
por: Peres, Tanara V., et al.
Publicado: (2016)

Neuroprotective Effects of Quercetin in Alzheimer’s Disease
por: Khan, Haroon, et al.
Publicado: (2019)

Neuroprotective Natural Products for Alzheimer’s Disease
por: Chen, Xin, et al.
Publicado: (2021)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
por: M Yelanchezian, Y Mukish, et al.
Publicado: (2022)

The Neuroprotective Potentiality of Flavonoids on Alzheimer’s Disease
por: Calderaro, Antonella, et al.
Publicado: (2022)

Neuroprotective effects of statins against amyloid β-induced neurotoxicity
por: Li, Hsin-Hua, et al.
Publicado: (2018)

Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
por: Couttas, Timothy A, et al.
Publicado: (2014)

Uncoupling protein 2 in the glial response to stress: implications for neuroprotection
por: Hass, Daniel T., et al.
Publicado: (2016)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
por: Mounsey, Ross B., et al.
Publicado: (2010)

Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity
por: Hassanzadeh, Gholamreza, et al.
Publicado: (2011)

Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer’s disease and the role of glial cells
por: Gao, Yanpan, et al.
Publicado: (2022)

Pathogenesis of Alzheimer’s disease
por: Swerdlow, Russell H
Publicado: (2007)

Retinal glial changes in Alzheimer's disease – A review
por: Fernández-Albarral, José A., et al.
Publicado: (2019)

The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy
por: Nirzhor, Saif Shahriar Rahman, et al.
Publicado: (2018)

Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2022)

Neuronal Glial Crosstalk: Specific and Shared Mechanisms in Alzheimer’s Disease
por: Chavda, Vishal, et al.
Publicado: (2022)

Biological agents and the aging brain: glial inflammation and neurotoxic signaling
por: Latham, Amanda S., et al.
Publicado: (2023)

Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review
por: Di Giacomo, Silvia, et al.
Publicado: (2022)

Mercury-induced neurotoxicity and neuroprotective effects of berberine
por: Moneim, Ahmed E. Abdel
Publicado: (2015)

Neuroprotective effect of selumetinib on acrolein-induced neurotoxicity
por: Huang, Hui-Ju, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8lfj5j9ro3qlas34na6nevqn2